RNaseOUT Recombinant Ribonuclease Inhibitor
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0474789
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $232.26
About this award
The University of Virginia awarded contract A207_PO-0474789 to Life Technologies Corporation on August 29, 2026. The contract pertains to the procurement of RNaseOUT Recombinant Ribonuclease Inhibitor, a single unit to be delivered to Anna Olson. The cumulative contract value is $232.00. This award represents a straightforward goods procurement transaction within the Commonwealth of Virginia.
Life Technologies Corporation, as the prime contractor, is responsible for fulfilling the delivery of the ribonuclease inhibitor product to the specified recipient at the University of Virginia. The contract documentation identifies only the cumulative value at $232.00, with individual unit pricing at $232.26. No additional performance period, annual value breakdown, or alternative line items are specified in the available contract award information.
Line items
| Item | Total |
|---|---|
| RNaseOUT Recombinant Ribonuclease Inhibitor | $232.26 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0474789?
Contract A207_PO-0474789 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on August 29, 2026.
How much is contract A207_PO-0474789 worth?
Its cumulative value is $232.26.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award